Dupilumab Subcutaneous and Leuprolide Injection (CPP)
Determining the interaction of Dupilumab Subcutaneous and Leuprolide Injection (CPP) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dupilumab
Brand name: Dupixent
Synonyms: Dupilumab
Generic Name: leuprolide
Brand name: Eligard, Lupron Depot, Lupron, Lupron Depot-Ped, Lupron Depot-Gyn, Viadur
Synonyms: Leuprolide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dupilumab Subcutaneous-Leuprolide Injection (Prostate)
- Dupilumab Subcutaneous-Leuprolide Injection (Women)
- Dupilumab Subcutaneous-Leuprolide Intramuscular, Subcutaneous, Intradermal, Injection
- Dupilumab Subcutaneous-Leustatin
- Dupilumab Subcutaneous-Leustatin injection
- Dupilumab Subcutaneous-Leva Set
- Leuprolide Injection (CPP)-Dupixent
- Leuprolide Injection (CPP)-Duplex T Topical
- Leuprolide Injection (CPP)-Durachol
- Leuprolide Injection (CPP)-Duraclon
- Leuprolide Injection (CPP)-Duraclon injection
- Leuprolide Injection (CPP)-Duraflu